Pages that link to "Q34344042"

The following pages link to Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children (Q34344042):

Displaying 43 items.

• Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age (Q24245934) (← links)
• Passive immunity in prevention and treatment of infectious diseases (Q24550699) (← links)
• Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response (Q24650974) (← links)
• Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis (Q33768943) (← links)
• A step ahead. Infant protection through maternal immunization (Q33889592) (← links)
• Middle ear effusion in children (Q33894891) (← links)
• Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants (Q34077073) (← links)
• Maternal vaccines (Q34104527) (← links)
• Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge? (Q34133055) (← links)
• Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants (Q34205630) (← links)
• Vaccines in pregnancy (Q34218618) (← links)
• Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine (Q34288536) (← links)
• Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children (Q34393305) (← links)
• Prevention of otitis media by vaccination (Q34716929) (← links)
• Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins (Q35522733) (← links)
• Bacterial Polysaccharides as Vaccines — Immunity and Chemical Characterization (Q35554116) (← links)
• Anti-pneumococcal antibody titre measurement: what useful information does it yield? (Q36026175) (← links)
• Recent advances in pneumococcal vaccination of children (Q36048848) (← links)
• Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vacc (Q36313578) (← links)
• New vaccines for the prevention of pneumococcal infections (Q37091903) (← links)
• Glycoconjugate vaccines. (Q38044755) (← links)
• Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection (Q39510709) (← links)
• The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate (Q39831698) (← links)
• Current and Future Prospects for a Vaccine for Nontypeable Haemophilus influenzae (Q39987614) (← links)
• Immunological aspects of otitis media: present views on possibilities of immunoprophylaxis of acute otitis media in infants and children (Q40476874) (← links)
• New vaccines for prevention of pneumococcal infections (Q40520343) (← links)
• The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine (Q40552159) (← links)
• New concepts in the pathophysiology and management of middle ear disease in childhood (Q40957236) (← links)
• Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses (Q40994858) (← links)
• New prospects in the prevention of otitis media (Q41227288) (← links)
• Immunologic Epitope, Gene, and Immunity Involved in Pneumococcal Glycoconjugate (Q41534149) (← links)
• The other effect of intravenously administered respiratory syncytial virus-enriched immune globulin for prophylaxis: less acute otitis media (Q45768846) (← links)
• Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. (Q46085069) (← links)
• Pneumococcal polysaccharide vaccine in children with chronic renal disease: a prospective study of antibody response and duration (Q47188147) (← links)
• Vaccination against middle-ear bacterial and viral pathogens (Q48003546) (← links)
• Immunology of the middle ear: role of local and systemic antibodies in clearance of viruses and bacteria (Q48003674) (← links)
• Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. (Q51953457) (← links)
• Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. (Q52029594) (← links)
• Antibodies to Pneumolysin and Pneumococcal Capsular Polysaccharides in Middle Ear Fluid of Children with Acute Otitis Media (Q58282738) (← links)
• Immune globulin administration as an approach to prevention of acute otitis media (Q72577747) (← links)
• Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media (Q73407350) (← links)
• Passive immunization for the prevention of otitis media (Q73407364) (← links)
• Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid (Q78036108) (← links)